Sherman Asset Management Inc. Takes Position in Colgate-Palmolive (NYSE:CL)

Sherman Asset Management Inc. purchased a new stake in shares of Colgate-Palmolive (NYSE:CL) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 782 shares of the company’s stock, valued at approximately $71,000.

Several other large investors also recently bought and sold shares of CL. Swedbank AB increased its holdings in Colgate-Palmolive by 1.4% in the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after buying an additional 40,324 shares in the last quarter. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive in the 3rd quarter worth about $42,000. Stephens Inc. AR increased its holdings in Colgate-Palmolive by 2.1% in the 3rd quarter. Stephens Inc. AR now owns 11,951 shares of the company’s stock worth $1,241,000 after buying an additional 251 shares in the last quarter. Creative Financial Designs Inc. ADV increased its holdings in Colgate-Palmolive by 142.1% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 869 shares of the company’s stock worth $90,000 after buying an additional 510 shares in the last quarter. Finally, Gladstone Institutional Advisory LLC increased its holdings in Colgate-Palmolive by 10.3% in the 3rd quarter. Gladstone Institutional Advisory LLC now owns 6,758 shares of the company’s stock worth $702,000 after buying an additional 631 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Up 1.2 %

NYSE CL opened at $91.27 on Friday. The stock’s 50 day moving average is $88.74 and its 200 day moving average is $95.48. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The stock has a market cap of $74.07 billion, a PE ratio of 25.93, a P/E/G ratio of 4.20 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the firm posted $0.87 EPS. Research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.

Analysts Set New Price Targets

CL has been the subject of several research analyst reports. Raymond James reiterated an “outperform” rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Piper Sandler cut their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Finally, Barclays cut their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.